Ejaculation-Preserving Bipolar Prostate Enucleation for BPH
Official title: Bipolar Transurethral Enucleation of the Prostate With Preservation of Ejaculation in Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Trial
Run by Beni-Suef University · NCT07629479 · Data updated 2026-11-12
This randomized trial tests whether a modified ejaculation-preserving bipolar TUEP can maintain ejaculation while still relieving urinary symptoms in sexually active men with BPH who didn’t improve with meds.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | Men only |
| Enrollment | 60 (estimated) |
| Sponsor | Beni-Suef University Academic / other |
| Locations | 1 site (Banī Suwayf, Beni Suweif Governorate) |
| Status | Recruiting |
| Started | September 8, 2025 |
| Main results expected | August 2026 |
| Study ends | September 2026 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT07629479 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Sexually active men with BPH and lower urinary tract symptoms who failed medical therapy and meet specific prostate size and health criteria.
✕Probably not a fit
Patients with preexisting sexual dysfunction, cancer suspicion, neurological disorders affecting urinary or sexual function, or inability to consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective randomized trial compares an ejaculation-preserving modification of bipolar transurethral enucleation of the prostate (B-TUEP) to the standard B-TUEP in sexually active men with benign prostatic hyperplasia and lower urinary tract symptoms after failure of medical therapy. Participants are assigned 1:1 to either the ejaculation-preserving technique or the standard procedure, and outcomes include ejaculatory and erectile function, urinary symptom scores, urine flow metrics, residual urine, perioperative complications, and need for retreatment over follow-up. The ejaculation-preserving approach maintains paracollicular tissue and nearby structures to try to preserve ejaculation, while the control uses the conventional enucleation approach. Validated questionnaires and objective urinary parameters assess functional outcomes. The study aims to determine if the modified technique can achieve similar relief of symptoms with better preservation of sexual function.
Why it matters
Potential benefit: If successful, patients may experience preserved ejaculation without sacrificing urinary symptom relief or overall safety.
How similar studies have gone: Prior endoscopic prostate surgeries show functional trade-offs; this is a novel modification specifically aiming to preserve ejaculation, with limited precedent in this exact comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients with lower urinary tract symptoms secondary to benign prostatic obstruction after failed medical treatment for at least 3 months. * Sexually active patients with a continuous relationship with the same partner. * International Prostate Symptom Score of 8 or greater. * Transrectal ultrasound-estimated prostate size between 40 and 100 cc. * Eligible for bipolar transurethral enucleation of the prostate. * Ability to complete the required sexual and urinary function questionnaires. * Ability to provide written informed consent. Exclusion Criteria: * Preoperative sexual dysfunction. * Preoperative ejaculatory dysfunction. * Diagnosis or suspicion of prostate cancer. * Neurological disorders affecting lower urinary tract or sexual function. * Detrusor hypocontractility. * Catheter-dependent patients. * Patients with bladder stones. * Inability or refusal to provide informed consent.
Where it's running
-
Department of Urology- Beni-Suef University Hospitals
Banī Suwayf, Beni Suweif Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Hany F Badawy, MD — Faculty of medicine Beni-Suef University
- Study coordinator: Hany F Badawy, MD
- Email: HANYFATHY86@GMAIL.COM
- Phone: +201149525028
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate
This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.
-
Tamsulosin With or Without Tadalafil for a Trial Without Catheter After Acute Urinary Retention
This study tests whether adding tadalafil to tamsulosin helps men with a first episode of acute urinary retention due to enlarged prostate pass urine without needing a catheter.
-
Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia
This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.
-
Water Vapor Therapy versus Ejaculation-Preserving HoLEP for Benign Prostatic Hyperplasia
This study compares Rezum water vapor therapy to ejaculation-preserving HoLEP in sexually active men with moderate-to-severe symptoms from BPH to see which preserves ejaculation better while easing urinary symptoms.
-
Global registry for benign prostatic hyperplasia treatments
This study is collecting information from men with benign prostatic hyperplasia to see how different treatments work and to help improve future care.
-
Registry for assessing treatments of benign prostatic hyperplasia
This study is collecting information to see how well different treatments for enlarged prostate symptoms work, comparing new options with traditional ones for men aged 18 and older.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.